DNMT3A and acute lymphoblastic leukemia: Cumulatively, these studies reveal that DNMT3A mutations promote survival and chemotherapy resistance in cells from patients with T-ALL and identify BIRC5 as a specific genetic dependency of DNMT3A-mutant T-ALL cells.